相似文献
1
Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin.
BMJ. 2007 Feb 10;334(7588):312-5. doi: 10.1136/bmj.39090.709537.47.
2
Bidirectional ventricular tachycardia resulting from digoxin and amiodarone treatment of rapid atrial fibrillation.
Am J Emerg Med. 2004 May;22(3):235-6. doi: 10.1016/j.ajem.2004.02.034.
3
Dronedarone-induced digoxin toxicity: new drug, new interactions.
Am J Ther. 2013 Nov-Dec;20(6):e717-9. doi: 10.1097/MJT.0b013e31821106c9.
4
A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Ann Emerg Med. 2000 Jul;36(1):1-9. doi: 10.1067/mem.2000.107655.
5
6
Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation.
Sci Rep. 2020 Mar 5;10(1):4101. doi: 10.1038/s41598-020-61065-4.
7
Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration.
Pharmacotherapy. 2007 Mar;27(3):472-5. doi: 10.1592/phco.27.3.472.
8
Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial.
Am Heart J. 2004 Jan;147(1):E3. doi: 10.1016/s0002-8703(03)00526-x.
9
Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study.
Osteoporos Int. 2007 Apr;18(4):409-17. doi: 10.1007/s00198-006-0250-7. Epub 2006 Nov 9.
10
Amiodarone use is associated with increased risk of stroke in patients with nonvalvular atrial fibrillation: a nationwide population-based cohort study.
Medicine (Baltimore). 2015 May;94(19):e849. doi: 10.1097/MD.0000000000000849.
引用本文的文献
1
[Antiarrhythmic drugs in the present day].
Inn Med (Heidelb). 2024 Aug;65(8):762-769. doi: 10.1007/s00108-024-01745-9. Epub 2024 Jul 15.
2
Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications.
Int J Environ Res Public Health. 2021 Dec 8;18(24):12936. doi: 10.3390/ijerph182412936.
3
Epidemiology and cost analysis of pharmacist interventions at Ghent University Hospital.
Int J Clin Pharm. 2012 Oct;34(5):773-8. doi: 10.1007/s11096-012-9676-5. Epub 2012 Jul 19.
4
Ventricular arrhythmia in children: diagnosis and management.
Curr Treat Options Cardiovasc Med. 2008 Sep;10(5):442-7. doi: 10.1007/s11936-008-0036-7.
本文引用的文献
1
Best practice in primary care pathology: review 4.
J Clin Pathol. 2006 Sep;59(9):893-902. doi: 10.1136/jcp.2005.035212. Epub 2006 May 19.
2
Monitoring amiodarone's toxicities: recommendations, evidence, and clinical practice.
Clin Pharmacol Ther. 2004 Jan;75(1):110-22. doi: 10.1016/j.clpt.2003.09.010.
3
Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy.
Chest. 2002 Jan;121(1):19-23. doi: 10.1378/chest.121.1.19.
4
Lithium monitoring before and after the distribution of clinical practice guidelines.
Acta Psychiatr Scand. 2000 May;101(5):349-53. doi: 10.1034/j.1600-0447.2000.101005349.x.
5
Controversial aspects of thyroid disease.
BMJ. 1999 Oct 2;319(7214):894-9. doi: 10.1136/bmj.319.7214.894.
6
Evaluating the appropriateness of digoxin level monitoring.
Arch Intern Med. 1999 Feb 22;159(4):363-8. doi: 10.1001/archinte.159.4.363.
7
Techniques to improve physicians' use of diagnostic tests: a new conceptual framework.
JAMA. 1998 Dec 16;280(23):2020-7. doi: 10.1001/jama.280.23.2020.
8
Appropriateness of antiepileptic drug level monitoring.
JAMA. 1995;274(20):1622-6.
9
Hypomagnesaemia in elderly digitalised patients.
Scott Med J. 1988 Jun;33(3):273-4. doi: 10.1177/003693308803300309.
10
Therapeutic drug monitoring reduces toxic drug reactions: a meta-analysis.
Ther Drug Monit. 1990 Jan;12(1):72-8. doi: 10.1097/00007691-199001000-00013.
Zotero 插件